# BRIEF Bendamustine and Rituximab In Elderly Follicular

> **NCT01313611** · PHASE2 · TERMINATED · sponsor: **The Lymphoma Academic Research Organisation** · enrollment: 62 (actual)

## Conditions studied

- Follicular Lymphoma

## Interventions

- **DRUG:** Rituximab + bendamustine

## Key facts

- **NCT ID:** NCT01313611
- **Lead sponsor:** The Lymphoma Academic Research Organisation
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-02
- **Primary completion:** 2012-10
- **Final completion:** 2017-12
- **Target enrollment:** 62 (ACTUAL)
- **Why stopped:** Treament with rituximab during maintenance phase was stoped, according to DSMC recommendations, since 3 cases of deaths occured.
- **Last updated:** 2018-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01313611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01313611, "BRIEF Bendamustine and Rituximab In Elderly Follicular". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01313611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*